Two gene-expression-based reference laboratory tests, MammaPrint® and Oncotype Dx®, are available for prognostication of patients diagnosed with breast cancer. This Review provides a conceptual and practical overview of these two tests and describes the clinical contexts for which these assays were developed so oncologists can select the most appropriate assay based on specific clinical contexts.
- Chungyeul Kim
- Soonmyung Paik